Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Cash from Investing (TTM): 207.79M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 207.79M |
June 30, 2023 | 283.92M |
March 31, 2023 | 371.40M |
December 31, 2022 | 225.80M |
September 30, 2022 | -4.332M |
June 30, 2022 | -17.57M |
March 31, 2022 | -83.82M |
December 31, 2021 | -588.90M |
September 30, 2021 | -477.40M |
June 30, 2021 | -413.95M |
March 31, 2021 | -473.16M |
December 31, 2020 | -139.86M |
September 30, 2020 | -87.46M |
June 30, 2020 | -279.68M |
March 31, 2020 | -263.16M |
December 31, 2019 | -176.14M |
September 30, 2019 | -232.88M |
June 30, 2019 | -76.06M |
March 31, 2019 | -95.90M |
December 31, 2018 | -145.76M |
September 30, 2018 | -71.04M |
June 30, 2018 | -86.03M |
March 31, 2018 | -52.52M |
December 31, 2017 | -8.651M |
September 30, 2017 | -1.051M |
Date | Value |
---|---|
June 30, 2017 | -1.264M |
March 31, 2017 | -2.643M |
December 31, 2016 | 38.26M |
September 30, 2016 | -25.10M |
June 30, 2016 | -21.36M |
March 31, 2016 | -19.95M |
December 31, 2015 | -50.75M |
September 30, 2015 | 3.874M |
June 30, 2015 | -7.51M |
March 31, 2015 | -9.516M |
December 31, 2014 | 24.22M |
September 30, 2014 | -26.10M |
June 30, 2014 | -28.97M |
March 31, 2014 | -26.78M |
December 31, 2013 | -29.47M |
September 30, 2013 | 4.049M |
June 30, 2013 | 2.52M |
March 31, 2013 | 0.084M |
December 31, 2012 | 0.055M |
September 30, 2012 | 11.68M |
June 30, 2012 | 15.87M |
March 31, 2012 | -18.46M |
December 31, 2011 | -17.88M |
September 30, 2011 | -22.69M |
June 30, 2011 | -26.82M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-588.90M
Minimum
Dec 2021
371.40M
Maximum
Mar 2023
-123.64M
Average
-113.66M
Median
Cash from Investing (TTM) Benchmarks
Bristol-Myers Squibb Co | -21.70B |
Karuna Therapeutics Inc (DELISTED) | -160.32M |
Puma Biotechnology Inc | -20.76M |
NovaBay Pharmaceuticals Inc | 1.062M |
Palatin Technologies Inc | 9.41M |